Current Clinical Landscape and Global Potential of Bacteriophage Therapy
Viruses · 21.04.2023 · 15 (4) · 1020
DOI: 10.3390/v15041020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 21.04.2023. Verfasst von Nicole Marie Hitchcock und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Missouri, Columbia, MO 65201, USA. Hauptthemen laut MEDLINE: Bacterial Infections, Phage Therapy, Bacteriophages. Die Arbeit wurde bisher 193-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In response to the global spread of antimicrobial resistance, there is an increased demand for novel and innovative antimicrobials. Bacteriophages have been known for their potential clinical utility in lysing bacteria for almost a century. Social pressures and the concomitant introduction of antibiotics in the mid-1900s hindered the widespread adoption of these naturally occurring bactericides. Recently, however, phage therapy has re-emerged as a promising strategy for combatting antimicrobial resistance. A unique mechanism of action and cost-effective production promotes phages as an ideal solution for addressing antibiotic-resistant bacterial infections, particularly in lower- and middle-income countries. As the number of phage-related research labs worldwide continues to grow, it will be increasingly important to encourage the expansion of well-developed clinical trials, the standardization of the production and storage of phage cocktails, and the advancement of international collaboration. In this review, we discuss the history, benefits, and limitations of bacteriophage research and its current role in the setting of addressing antimicrobial resistance with a specific focus on active clinical trials and case reports of phage therapy administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Missouri, Columbia, MO 65201, USA.
- SENAI Institute of Innovation (ISI) in Health Advanced Systems, University Center SENAI/CIMATEC, Salvador 41650-010, BA, Brazil.
- Gonçalo Moniz Institute, FIOCRUZ, Salvador 40291-710, BA, Brazil.
- School of Medicine, University of California San Diego, San Diego, CA 92093, USA.
- Elson S. Floyd College of Medicine, Washington State University, Spokane, WA 99202, USA.
ORCID-Profile: Danielle Devequi Gomes Nunes, Job Shiach, Josiane Dantas Viana Barbosa, Brahm Seymour Coler
Zitieren
APA
Hitchcock, N. M., Devequi Gomes Nunes, D., Shiach, J., Valeria Saraiva Hodel, K., Dantas Viana Barbosa, J., Alencar Pereira Rodrigues, L., Coler, B. S., Botelho Pereira Soares, M., & Badaró, R. (2023). Current Clinical Landscape and Global Potential of Bacteriophage Therapy. Viruses, 15(4), 1020. https://doi.org/10.3390/v15041020
Vancouver
Hitchcock NM, Devequi Gomes Nunes D, Shiach J, Valeria Saraiva Hodel K, Dantas Viana Barbosa J, Alencar Pereira Rodrigues L, et al. Current Clinical Landscape and Global Potential of Bacteriophage Therapy. Viruses. 2023;15(4):1020. doi:10.3390/v15041020
BibTeX
@article{Hitchcock2023,
author = {Hitchcock, Nicole Marie and Devequi Gomes Nunes, Danielle and Shiach, Job and Valeria Saraiva Hodel, Katharine and Dantas Viana Barbosa, Josiane and Alencar Pereira Rodrigues, Leticia and Coler, Brahm Seymour and Botelho Pereira Soares, Milena and Badaró, Roberto},
title = {Current Clinical Landscape and Global Potential of Bacteriophage Therapy},
journal = {Viruses},
year = {2023},
volume = {15},
number = {4},
pages = {1020},
doi = {10.3390/v15041020}
}
EUVIMED